13F
中

RAPP RAPPORT THERAPEUTICS INC

2026Q1 · CUSIP 75383L102 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
146
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
86
Δ whales
+11
Inst. holding value
$1.6B
New positions
30
Closed positions
28
Price momentum (1Q)
+21.1%
Put / Call
1/1

Breadth history (34 quarters)

2024Q3: Δ+20 · h=55 2024Q4: Δ+16 · h=71 2025Q1: Δ+7 · h=78 2025Q2: Δ+5 · h=83 2025Q3: Δ+41 · h=124 2025Q4: Δ+20 · h=144 2026Q1: Δ+2 · h=146 2024Q3: holders=55 2024Q4: holders=71 2025Q1: holders=78 2025Q2: holders=83 2025Q3: holders=124 2025Q4: holders=144 2026Q1: holders=146 -41 -20.5 +0 +20.5 +41 49102154 24Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 6% +19.4% +42.3%
2024Q3 Top 17% -40.6% -47.9%

Options Sentiment

Put holders
1
QoQ: 0
Call holders
1
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.60
EPS YoY
-139.3%
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-09-30: EPS -0.50 2025-03-31: EPS -0.68 2025-06-30: EPS -0.75 2025-09-30: EPS -0.71 2025-12-31: EPS -0.72 2026-03-31: EPS -0.42 -0.82 -0.41 0.00 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)